Tamoxifen
About
Therapy type: Hormone therapy
Therapy strategy: Estrogen receptor inhibition
Mappings
NCI Thesaurus: Tamoxifen (ncit:C62078)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | ER positive, HER2-negative | Invasive Breast Carcinoma | Abemaciclib, Tamoxifen | |
| Sensitivity (+) | HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Tamoxifen | |
| Sensitivity (+) | ER positive, HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Tamoxifen | |
| Sensitivity (+) | ER positive | Invasive Breast Carcinoma | Tamoxifen | |
| Sensitivity (+) | ER positive | Invasive Breast Carcinoma | Tamoxifen | |
| Sensitivity (+) | ER positive, HER2-negative | Invasive Breast Carcinoma | Abemaciclib, Tamoxifen | |
| Sensitivity (+) | HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Tamoxifen | |
| Sensitivity (+) | ER positive, HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Tamoxifen |